3/18
03:09 pm
cvkd
Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Low
Report
Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.